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The reliability of lipidomics, an approach to identify the presence and interactions of lipids, to 
analyze the bone marrow lipid composition among pediatric populations with bone fragility is 
unknown. The objective of this study was to assess the test-retest reliability, standard error of 
measurement (SEM), and the minimal detectable change (MDC) of vertebral bone marrow lipid 
composition determined by targeted lipidomics among children with varying degrees of bone 
fragility undergoing routine orthopedic surgery. Children aged 10-19 years, with a confirmed 
diagnosis of adolescent idiopathic scoliosis (n=13) or neuromuscular scoliosis and cerebral palsy 
(n=3), undergoing posterior spinal fusion surgery at our institution were included in this study. 
Transpedicular vertebral body bone marrow samples were taken from thoracic vertebrae 
(T11,12) or lumbar vertebrae (L1-4). Lipid composition was assessed via targeted lipidomics and 
all samples were analyzed in the same batch. Lipid composition measures were examined as the 
saturated, monounsaturated, and polyunsaturated index and as individual fatty acids. Relative 
and absolute test-retest reliability was assessed using the intraclass correlation coefficient (ICC), 
SEM, and MDC. Associations between demographics and index measures were explored. The 
ICC (95% confidence interval [CI]), SEM, and MDC was 0.81 (0.55-0.93), 1.6%, and 4.3%, 
respectively, for the saturated index, 0.66 (0.25-0.87), 3.5%, and 9.7%, respectively, for the 
monounsaturated index, and 0.60 (0.17-0.84), 3.6%, and 9.9%, respectively, for the 
polyunsaturated index. For the individual fatty acids, the ICC showed a considerable range from 
0.04 (22:2n-6) to 0.97 (18:3n-3). Age was positively correlated with the saturated index (r2=0.36; 
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P=0.014) and negatively correlated with the polyunsaturated index (r2=0.26; P=0.043); there was 
no difference in index measures by sex (P>0.58). The test-retest reliability was moderate-to-good 
for index measures and poor to excellent for individual fatty acids; this information can be used 
to power research studies and identify measures for clinical or research monitoring.  
Keywords: lipidomics; scoliosis; cerebral palsy; reliability; bone marrow lipids 
  




Several investigations, some dating as far back as the 1970s, have demonstrated an 
inverse relationship between bone mass and bone marrow adiposity in humans and animals.(1-9) 
Bone marrow pluripotent mesenchymal progenitor cells are the shared origin for osteoblasts 
(bone forming cells) and bone marrow adipocytes (lipid-containing cells),(10) among other cell 
lineages,(11) thus giving rise to bone marrow adipose tissue at the expense of bone(8,9,12) (and 
hematopoietic(9)) tissue. More recent evidence suggests that bone marrow adipose tissue 
possesses biological features that may be implicated in the pathogenesis of bone (and other 
organ) disease. As a result, there is a growing interest in bone marrow adipose tissue biology and 
its implications for bone and systemic energy metabolism (for reviews, please see(13-18)).  
 The lipid composition of bone marrow is of interest as it may serve as a key regulator in 
bone homeostasis. For example, some fatty acids, such as palmitic and stearic saturated fatty 
acids, may be lipotoxic to bone(19,20) and impede osteoblast function,(21,22) while other fatty acids, 
such as palmitoleic, oleic, and linoleic unsaturated fatty acids, may promote osteoblast 
differentiation, mineralization, and survival,(20,22,23) and inhibit osteoclast differentiation and 
function.(24,25) Given the association with bone fragility,(26,27) the bone marrow saturated index- 
which is the proportion of saturated fatty acids to total fatty acids- has been suggested as a 
biomarker for osteoporosis.(28)  
To date, many of the studies examining the interplay between bone and bone marrow 
adipose tissue have focused on adults, animal models, or in vitro experiments.(13-18) Growth and 
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development is an essential window for maximizing bone health. Factors that impede typical 
bone acquisition during growth and development will not only diminish peak bone mass 
attainment, but can have lasting adverse ramifications on bone health throughout the lifespan. 
Accordingly, recent attention is shining the light on bone marrow adipose tissue as a potential 
untapped source involved in bone acquisition during development, especially for pediatric 
patients with varying degrees of bone fragility,(18,29) such as mild osteoporosis noted in the spine 
in adolescent idiopathic scoliosis (AIS) and the profound fragility in cerebral palsy (CP).(30-32) 
Individuals with AIS and CP can have progressive scoliosis and may undergo spinal fusion 
surgery for correction of scoliosis. This provides a unique resource for acquiring pediatric bone 
and marrow samples to facilitate therapeutic and mechanistic research in the bone marrow 
adipose tissue arena with direct clinical relevance.  
Lipidomics is a branch of metabolomics that seeks to identify the presence, abundance, 
diversity, and interactions of lipids in biological systems, and is a rapidly developing discipline 
making significant biomedical advances in the area of lipid biology.(33) Using lipidomics to 
assess bone marrow lipid composition from children with AIS and CP is particularly attractive as 
it presents the opportunity to comprehensively analyze the bone marrow lipidome to drive 
research directions and address specific biological questions. To date, the reliability of 
lipidomics to analyze the bone marrow lipid composition among pediatric populations with bone 
fragility has yet to be determined. This is particularly important for bone marrow as this tissue 
has a highly heterogeneous cellular pool with unknown cellular and tissue-type distribution for 
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pediatric populations with bone fragility. Therefore, to help interpret bone marrow lipid 
composition measures in the clinical and research setting and to provide novel information to 
help power research studies where pediatric bone marrow lipid composition is a measure(s) of 
interest, reliability assessment is imperative. Accordingly, the purpose of this study was to assess 
the test-retest reliability, standard error of measurement (SEM), and the minimal detectable 
change (MDC) of vertebral bone marrow lipid composition determined by targeted lipidomics 




With IRB approval, participants aged 10-19 years, with a confirmed diagnosis of AIS or 
CP, and who were undergoing routine posterior spinal fusion surgery in the same pediatric 
orthopedic clinic at the University of Michigan were eligible for this study. Parental consent and 
where appropriate patient assent was obtained to use the transpedicular vertebral body bone 
marrow samples collected from surgery, and to obtain diagnosis and basic demographic 
information, including date of birth, sex, and race for all participants. Additional information was 
collected from children with CP, including type of CP and the gross motor function classification 
system (GMFCS). The GMFCS ranks the severity of motor impairment on a roman numeral 
scale from I to V, coinciding with mild to severe motor impairment, respectively.(34) Bone 
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marrow samples were obtained from children with spastic type CP and classified as GMFCS IV 
and V.    
 
Bone marrow sample extraction 
 Bone marrow was extracted from the vertebral body via the pedicle in the lumbar and 
lower thoracic spine, based on the planned spinal fusion instrumentation construct, using an 18-
gauge needle and syringe. Bone marrow aspirates were immediately placed on wet ice and kept 
cold until processing. Samples for lipidomics were divided into 1mL aliquots and stored at -80°C 
until analysis. Of the 34 children that met eligibility criteria for the study and had at least 1mL of 
vertebral bone marrow, 16 children had two 1mL aliquots of bone marrow collected from the 
same site, during the same surgery, and by the same two physicians (co-author MSC, n=15; co-
author YL, n=1) from vertebrae T11-L4 and were analyzed in this study. These two 1mL bone 
marrow aliquots are referred to as sample 1 and sample 2 hereafter. Since bone marrow tissue is 
heterogeneous, the research question centers around reliability of extracting bone marrow during 
routine orthopedic surgery and how much variability exists in adjacent marrow tissue. Therefore, 
the goal of this study was to assess the reliability of different segments of the extracted marrow 
for lipidomics rather than the precision or repeatability of the lipidomics technique using the 
same exact sample (e.g., intra-sample variability).  
 
Lipidomics  
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 Samples were sent to the Michigan Nutrition Obesity Research Center Lipidomics Core 
for targeted lipidomics using established procedures and the Total Lipid Extraction and Thin-
Layer Chromatography Cleanup assay by an experienced technician. Briefly, for each bone 
marrow sample, lipids were extracted using a modified Bligh-Dyer method of solvent 
partition.(35) An aliquot of 100µL was taken and 200µL of water was added. Total lipids were 
extracted after adding 2.25mL of chloroform-methanol (1:2) containing 0.01 % butylated 
hydroxytoluene and 10µL of 4 mM heptadecanoic acid (C17:0) as an internal standard. The 
mixtures were thoroughly homogenized on a vortex, treated with 0.75mL of chloroform and 
0.75mL of NaCL (0,9%) solution, and then mixed and centrifuged on a table top centrifuge at 
3,000rpm for 15 minutes, after which a clear separation between the two layers were observed. 
The lower organic layer (chloroform) contained the lipids and was transferred into another set of 
tubes and saved at -20°C until further analysis. 
 The fatty acids were broken down into their methyl esters via trans esterification with 
BF3-methanol using a modified method, as previously described.(36) The fatty acid methyl esters 
(FAMEs) were extracted by adding 2mL of hexane and 1mL of water, mixing and centrifuging 
followed by collecting them in the upper hexane layers. The solvents were then removed under 
nitrogen and the crude FAMEs were re-dissolved in a small volume of chloroform and purified 
on a thin layer chromatographic (TLC) plate (20 x 20cm, silica gel 60, Merck, Germany). The 
plate was developed with a solvent mixture of hexane-diethyl ether-acetic acid. Methyl ester 
bands were then identified by comparing the retention flow of the authentic standard and the 
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contents from the TLC powders were extracted with chloroform. The solvents were removed 
under nitrogen and methyl esters were re-dissolved in a small volume of hexane (100-200µL) 
and the fatty acid compositions of the lipids were analyzed by gas chromatography. 
 Analysis of FAMEs were performed by gas chromatography on an Agilent Gas 
Chromatography model 6890N with flame ionization detector, an auto sampler, and Chemstation 
software for analysis. The gas chromatography column used was Agilent HP 88, 30 meter, 
0.25mm I.D. and 0.20µm film thickness. Hydrogen was used as a carrier gas as well as for the 
flame ionization detector. Nitrogen was used as a makeup gas. Analyses were carried out with a 
temperature program of 125°C to 220°C. One µL of sample was injected by the auto sampler and 
each sample was analyzed in 20 min. A calibration curve was prepared running known amounts 
of methyl heptadecanoate and other commercially available standard methyl ester mixtures 
containing saturated and unsaturated carbon chain length from 12 through 24 carbons on gas 
chromatography and using the peak area ratio response of each methyl ester with respect to 
methyl heptadecanoate. A mixture of authentic methyl esters was also run side by side to identify 
the components in unknown samples by comparing their retention times. The fatty acids were 
quantified with respect to the amounts of C17:0 internal standard added and the calibration curve 
prepared. The coefficient of variation for gas chromatography analyses was found to be within 
2.3 to 3.7%. 
 Measures were converted to relative abundance (%) for each fatty acid and the saturated, 
monounsaturated, and polyunsaturated indices were calculated as the proportion of the fatty acid 
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type (e.g., saturated) to the total fatty acid amount. The nomenclature used for individual fatty 
acids include the number of carbon chains, the number of double bonds, and for unsaturated fatty 
acids, the number of carbon chains after the double bond and cis (c) or trans (t) configuration. 
For example, stearic acid, 18:0, is a saturated fatty acid with 18 carbon chains and 0 double 
bonds; docosahexaenoic acid, 22:6n-3, is a polyunsaturated fatty acid with 22 carbon chains, 6 
double bonds, and the first double bond at the 3rd carbon chain from the omega end.  
 
Statistical analysis 
Test-retest reliability was assessed using relative and absolute estimates, including the 
intraclass correlation coefficient (ICC; relative estimate), SEM (absolute estimate), and MDC 
(absolute estimate). ICC reflects the degree of correlation and agreement between measures, 
which is a superior method for test-retest reliability assessment.(37) Following guidelines for 
selecting and reporting ICC for test-retest reliability,(37) ICC and 95% confidence interval (CI) 
was estimated using SPSS statistical package version 24 (SPSS Inc, Chicago, IL) based on a 2-
way mixed-effects model and absolute agreement. As a general rule, ICC<0.50 indicates poor 
reliability, ICC between 0.50 and 0.75 indicates moderate reliability, ICC between 0.75 and 0.90 
indicates good reliability, and ICC>0.90 indicates excellent reliability.(37) The SEM provides an 
estimate of the discrepancy between repeated measures, or intra-individual variability,(38) and 
was calculated as follows: SEM = SDpooled x √(1-ICC), where SDpooled is the pooled standard 
deviation of both sets of measures. The MDC provides an estimate of the minimal magnitude of 
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change that is required for the measure to be considered a real change rather than the result of 
random variation or measurement error at the 95% CI level.(39,40) The MDC was calculated as 
follows:(41) MDC95% = 1.96 x SEM x √2, where 1.96 comes from the z-score corresponding to 
the 95% CI and √2 accounts for the underlying uncertainty during measurement.  
 
Sensitivity analysis 
The reliability estimates are vulnerable to outliers and influential observations due to the 
small sample size. Outliers and influential observations were assessed using agreement and 
correlation methods for each lipid composition measure. Bland-Altman plots were constructed to 
evaluate the agreement between the two samples by regressing the difference between sample 1 
and sample 2 measures with the mean of the two sample measures.(42) The mean of the difference 
between bone marrow samples provides an estimate of the measure’s fixed bias, which was 
tested statistically using a one-sample t-test. Normality of the mean difference was assessed 
using skewness, kurtosis, and the Shapiro-Wilk test.  
Correlations between lipid composition measures from the two bone marrow samples 
were visually inspected using scatter plots. Outliers were assessed by Cook’s distance (Di), 
which identifies the strength of the influence of each data point (via residuals and leverage) on 
the regression between measures (the higher the Di value, the more influential the data point).(43) 
While a cutoff threshold of Di > 1.0 has been proposed in the presence of a large sample size,(44) 
we used a more conservative threshold of Di > 0.50 due to the small sample size for this study. It 
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is important to note that ICC reflects both the agreement and correlation.(37) The use of Bland-
Altman (agreement) and Di (correlation) as model diagnostics assesses each, but not both 
simultaneously. Nevertheless, for lipid composition measures that displayed potential outliers or 
had data points with Di > 0.50 (influential observations), ICC was re-assessed after removing the 




 We explored the association between age and sex with the index measures using bivariate 
regression analysis for age and the independent t-test for sex if the data were normally 
distributed, or the Mann-Whitney U test if the data were non-normally distributed. Other 
variables of interest (e.g., CP vs. AIS, race) had too few cases to perform analyses. 
  Data were analyzed using SPSS statistical package version 24 (SPSS Inc, Chicago, IL). 
An α level of 0.05 was used as the threshold to determine statistical significance. 
 
Results 
 Descriptive characteristics of the 16 participants are presented in Table 1. Notably, three 
of the 16 participants had spastic quadriplegic CP and were classified as GMFCS IV (n=1) or V 
(n=2), which is indicative of severe motor impairment. Of the 3 participants with CP, the bone 
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marrow samples came from L2 (n=1) and L4 (n=2). Of the 13 participants with AIS, the bone 
marrow samples came from T11 (n=4), T12 (n=4), L1 (n=3), L2 (n=1), and L4 (n=1).    
 The mean (± SD), ICC, SEM, and MDC of lipid composition measures from the 16 bone 
marrow samples are presented in Table 2, which is organized based on index vs. individual fatty 
acids, type of fatty acid (e.g., saturated), and the ICC point estimate from high to low. Based on 
the average of the first measurement (average of second measurement), 31.1% (31.4%) of the 
bone marrow lipids consisted of saturated fatty acids, while 33.9% (34.6%) and 34.9% (34.0%) 
consisted of monounsaturated and polyunsaturated fatty acids, respectively. 18:2n-6, 18:1n-9, 
and 16:0 were the most abundant fatty acids and 13:0, 12:0, and 22:2n-6 were the least abundant 
fatty acids.  
For the index measures, the ICC (and 95% CI) was 0.81 (0.55, 0.93) for the saturated 
index, suggesting good (moderate to excellent) reliability, and 0.66 (0.25, 0.87) and 0.60 (0.17, 
0.84) for the monounsaturated and polyunsaturated indices, respectively, suggesting moderate 
(poor to good) reliability. The SEM was 1.6%, 3.5%, and 3.6% for the saturated, 
monounsaturated, and polyunsaturated index, respectively, and the MDC was 4.3%, 9.7%, and 
9.9%, respectively. Figure 1 shows the scatter plots demonstrating the relationship between the 
index measures (A-C) and Bland-Altman plots for the agreement (D-F) between bone marrow 
samples for the index measures. Based on the Bland-Altman plots, the average bias was minimal 
(near zero) for each index measure and there was no evidence of fixed bias (all P>0.45 using a 
one-sample t-test).  
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The relative abundance of 13:0 was too low to detect and assess reliability. For all other 
fatty acids, the ICC (95% CI) exhibited a considerable range from 0.04 (-0.49, 0.52) to 0.97 
(0.92, 0.99). Based on the ICC point estimate of the 29 fatty acids where reliability estimates 
were obtained (i.e., excluding 13:0), 2 had excellent reliability (6.9%), 7 had good reliability 
(24.1%), 12 had moderate reliability (41.4%), and 8 had poor reliability (27.6%). Figure 2 shows 
the scatter plots (A-C) and Bland-Altman plots (D-F) of three fatty acids corresponding to the 
lowest (22:2n-6), middle (14:0), and highest (18:3n-3) ICC to represent the range of correlation 
and agreement among individual fatty acids. Based on the Bland-Altman plots, the average bias 
for these three representative fatty acids was minimal (near zero) and there was no evidence of 
fixed bias (all P>0.27 using a one-sample t-test). However, the mean difference was not 




 In addition to 22:2n-6 and 18:3n-3, there was evidence of an outlier or influential 
observation for 12 other individual fatty acids, but not for the index measures. However, only 1 
or 2 out of the 16 data points suggested a potential outlier or influential observation per fatty 
acid.  
 The mean (± SD), ICC, SEM, and MDC for the 14 fatty acids after removing the 
potential outliers or influential observations are presented in Table 3. The ICC value increased in 
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6 of the fatty acids, decreased in 6 of the fatty acids, and did not change or exhibited negligible 
change in 2 of the fatty acids. Some of the ICC values changed more drastically than others; e.g., 
ICC (95% CI) increased from 0.67 (0.29, 0.87) to 0.92 (0.77, 0.97) for 20:0, while 22:5n-3 
decreased from 0.85 (0.63, 0.95) to 0.74 (0.38, 0.90). Based on the ICC point estimate of the 29 
fatty acids where reliability estimates were obtained (i.e., excluding 13:0) and incorporating the 
values from the sensitivity analysis, 4 had excellent reliability (13.8%; 6.9% from primary 
analysis), 6 had good reliability (20.7%; 24.1% from primary analysis), 11 had moderate 
reliability (37.9%; 41.4% from primary analysis), and 8 had poor reliability (27.6%; same as 
primary analysis).  
 
Exploratory analysis 
 Age was significantly and positively correlated with the saturated index (r2=0.36; 
P=0.014) and significantly and negatively correlated with the polyunsaturated index (r2=0.26; 
P=0.043) (Figure 3) (results are presented for sample 1 but are consistent for both samples). 
There was no statistical difference between girls and boys for the saturated index (30.84 ± 2.86 
vs. 31.37 ± 4.55, P=0.78), monounsaturated index (34.68 ± 5.00 vs. 32.98 ± 7.31, P=0.59), 
polyunsaturated index (34.48 ± 6.15 vs. 35.65 ± 5.54, P=0.70), or age (14.74 ± 1.52 vs. 15.50 ± 
2.46, P=0.46) for this small sample (index results are presented for sample 1 but are consistent 
for both samples); however, all 9 girls had AIS whereas 3 out of 7 of the boys had CP, and bone 
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marrow was mostly extracted from the thoracic spine for girls (n=6) where boys it was the 
lumbar spine (n=5).  
 
Discussion 
 The findings from this study suggest moderate-to-good test-retest reliability for the 
vertebral bone marrow saturated and unsaturated index via targeted lipidomics from a small 
sample of children with AIS and CP using bone marrow collected under routine orthopedic 
surgical conditions. When we examined individual fatty acids, we observed a considerable range 
from poor to excellent test-retest reliability with approximately one-third having good to 
excellent (34.5%), moderate (37.9%), or poor (27.6%) test-retest reliability. In the exploratory 
analysis, we found that age was positively correlated with the saturated index and negatively 
correlated with the polyunsaturated index. These findings have important logistical implications 
for future research and clinical endeavors, because delineating the bone marrow lipid 
composition from pediatric populations with varying degrees of bone fragility may provide 
further insight into the role of bone marrow adipose tissue on bone and systemic energy 
metabolism that may be missed by only investigating the extent of fatty infiltration. Although, if 
and how bone marrow lipids contribute to skeletal acquisition and metabolism among children 
and adolescents is unknown.      
In the current study, we observed that the test-retest reliability of some fatty acids were 
sensitive to potential outliers or influential observations. Specifically, in the sensitivity analysis, 
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we observed 1 or 2 potential outliers or influential observations for 4 saturated fatty acids, 4 
monounsaturated fatty acids, and 6 polyunsaturated fatty acids exhibiting a range in relative 
abundance (<0.01% to 25.48%). It is important to note that these potential outliers or influential 
observations came from 10 different participants rather than the same or few participants, which 
may suggest the potential for considerable biological variability in bone marrow lipids between 
and within participants. While bone marrow consists of multiple cellular lineages, the cellular 
and tissue heterogeneity may be even greater or unique for individuals with bone fragility, such 
as AIS and CP. Factors related to AIS and CP that may influence the status of bone marrow lipid 
composition, and its variability within a given site, include nutrition, hormonal factors, 
comorbidities (e.g., cardiometabolic disease, inflammation), surgeries, and medications.(18,45,46) 
However, it is important to note that the variability may be due solely to or in conjunction with 
the small sample size, and we therefore urge caution in interpretation. Further, the current study 
found that age during this adolescent period was associated with a higher bone marrow saturated 
index and a lower polyunsaturated index, but none of these indices were associated with sex. 
These findings are consistent with studies that found higher marrow fat with age in the distal 
femur of 11 to 18 year olds with anorexia nervosa(47) and in L4 of typically developing 0 to 18 
year olds with no evidence of sex differences.(48) 
The reasons for the suboptimal reliability performance for some individual fatty acids are 
likely multifactorial. The relative abundance may be one of these reasons. While not presented in 
the Results section, when the relationship between the relative abundance of sample 1 and the 
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ICC value was examined for all 30 individual fatty acids, the r2 was 0.01 (P=0.530). However, 
when only fatty acids with less than 1% abundance were included (n=22), there was a stronger 
and positive correlation with the r2 at 0.32 (P=0.006). This may be due to logistical 
considerations for the fatty acids with very low abundance, such as detection sensitivity of the 
lipidomics technique or sample collection or processing methods that may elicit degradation of 
these fatty acids. For example, bone marrow fatty acid integrity may be impacted by collection 
methods (e.g., needle extraction may damage cell membranes), storage temperature (e.g., colder 
environments may limit enzyme activity and lipid degradation), duration of storage, and the 
number of freeze-thaw cycles,(49-55) especially for fatty acids with very low abundance. None of 
the samples in the current study underwent previous freeze-thaw cycles. Nevertheless, study 
findings have important implications for research and clinical investigation where biological 
effects of specific fatty acids from bone marrow may be of interest. Based on our findings using 
bone marrow collected during routine orthopedic surgical conditions, which may not be 
generalizable to other clinical populations or methods that are designed specifically for bone 
marrow extraction for analysis, we urge caution when assessing specific fatty acids with very 
low abundance from bone marrow due to the potential for poor reliability in measurement 
assessment.   
We observed that the SEM was 1.6%, 3.5%, and 3.6% for the saturated, 
monounsaturated, and polyunsaturated index, respectively, and that the SEM ranged from <0.1% 
to 5.8% for the individual fatty acids. These observations indicate the range of values around the 
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point estimate for each measure for intra-individual variability.(38) We observed that the MDC 
was 4.3%, 9.7%, and 9.9% for the saturated, monounsaturated, and polyunsaturated index, 
respectively, and that the MDC ranged from <0.1% to 16.0% for the individual fatty acids. These 
findings suggest that a change between repeated measurements larger than the MDC values 
could indicate a real change with 95% certainty among a similar sample. Seeing the considerable 
range of MDC, the degree of change needed to be considered a true change depends on the 
specific bone marrow lipid composition measure. These values can be used for power analysis 
and sample size calculation for research studies. Further consideration for longitudinal 
assessment is that the absolute abundance of some individual fatty acids may remain the same 
while others change drastically, thus impacting the relative abundance measure. How the 
interplay between relative and absolute measures impacts biological outcomes remains to be 
determined. 
It is important to note that there are other approaches to examine the composition of bone 
marrow that are less invasive. For example, bone marrow fat content using magnetic resonance 
spectroscopy has been used as a biomarker to distinguish skeletal fragility and altered metabolic 
states, such as type 2 diabetes,(27,56) and standard magnetic resonance imaging has been used to 
quantify the extent of bone marrow fat infiltration in pediatric populations.(30) A major advantage 
of in vivo imaging is in general the relatively high reproducibility, such as an ICC of 0.96 for 
bone marrow fat content in children with and without CP.(30) However, in vivo imaging 
techniques that are currently available for human research lack more granular information that 
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tissue extraction can provide, such as the degree of saturation and unsaturation using magnetic 
resonance spectroscopy(27,47,56) compared to quantifying individual fatty acids using tissue 
lipidomics.  
A major strength of this study is that, to our knowledge, this is the first study to assess the 
bone marrow lipid composition in children with varying degree of bone fragility and the first 
study to assess the test-retest reliability of bone marrow lipid profiles among children and 
adolescents. Further, the interest in the bone marrow adipose field is growing and acquiring bone 
marrow tissue from children and adolescents for research is rare. Therefore, this work provides 
novel and fundamental insights about the interpretability of bone marrow lipidomics among 
pediatric populations with bone fragility, and the use of human tissue facilitates data acquisition 
with direct clinical relevance. Although meaningful patterns did emerge, one limitation of this 
study is the small sample size. However, a large sample size is not feasible due to the invasive 
nature of acquiring bone marrow. Nevertheless, the findings from this sample size have practical 
implications as research studies that include clinical pediatric populations, such as AIS or CP, 
often have few participants due to logistical challenges, such as a low recruitment pool. 
Therefore, a sample size of 16 is not uncommon for such studies, especially for studies that 
require tissue extraction. Another limitation is the unknown site specific effect on reliability 
measures as we collected tissue from T11 to L4. However, even if there are differences in bone 
marrow lipid profiles along the vertebral column, the potential variability is less for reliability 
assessment in this study considering the tissue samples are collected from the same site (as 
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opposed to inter-site), immediately adjacent to one another, and collected during the same 
surgery. In this study, site specific variation of reliability would indicate vertebral differences in 
the degree of bone marrow tissue heterogeneity. While it is well documented that bone marrow 
tissue is highly heterogeneous in terms of a diverse cellular pool, we are unaware of any studies 
that have shown that the degree of heterogeneity differs by neighboring vertebral sites. Further, 
we examined the correlation and agreement by lumbar and thoracic sites (e.g., all figures), which 
provides little evidence of site specific effects. However, the sample size is small and we are 
therefore unable to conclusively determine the presence or absence of site specific effects on the 
reliability measures, SEM, and MDC. Finally, our exploratory analyses examined a small set of 
potential variables, which may be confounded by other age-related factors, such as height.      
 In conclusion, the test-retest reliability for vertebral bone marrow saturated and 
unsaturated index was moderate-to-good, and poor-to-excellent for individual fatty acids using 
targeted lipidomics from children with bone fragility in which bone marrow was collected during 
routine orthopedic surgery. Further, age, but not sex, was associated with a higher and lower 
saturated and polyunsaturated index, respectively, but the lack of sex difference may have been 
due to differences in the characteristics (e.g., CP). Future studies are needed to determine the 
interplay among bone, marrow, physiology, physical function, and disease for pediatric 
populations with bone fragility, not just for reliability assessment of the bone marrow lipidome, 
but also for clinical management, intervention, and optimizing peak bone mass attainment for 
these skeletally vulnerable populations.  





This work was supported by the University of Michigan Office of Health Equity and Inclusion 
Diversity Fund (Dr. Whitney), the National Institute of Child Health and Human Development of 
the National Institutes of Health (R03HD100443, Drs. Whitney, Alford, Devlin, Peterson, and 
Caird), and the American Academy of Cerebral Palsy and Developmental Medicine (Drs. 
Whitney and Peterson).  
 
Author contributions 
Study design: DGW. Study conduct: DGW, MJD, AIA, YL, MSC. Data collection: MJD, AIA, 
YL, MSC. Data analysis: DGW. Data interpretation: all authors. Drafting manuscript: DGW. 
Revising manuscript content: all authors. Approving final version of manuscript: all authors. 
DGW takes responsibility for the integrity of the data analysis.  
  




1. Meunier P, Aaron J, Edouard C, Vignon G. Osteoporosis and the replacement of cell populations 
of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clinical 
orthopaedics and related research. Oct 1971;80:147-54. Epub 1971/10/01. 
2. Minaire P, Edouard C, Arlot M, Meunier PJ. Marrow changes in paraplegic patients. Calcified 
tissue international. May 1984;36(3):338-40. Epub 1984/05/01. 
3. Martin RB, Zissimos SL. Relationships between marrow fat and bone turnover in ovariectomized 
and intact rats. Bone. 1991;12(2):123-31. Epub 1991/01/01. 
4. Di Iorgi N, Mo AO, Grimm K, Wren TA, Dorey F, Gilsanz V. Bone acquisition in healthy young 
females is reciprocally related to marrow adiposity. The Journal of clinical endocrinology and 
metabolism. Research Support, N.I.H., Extramural 
Research Support, U.S. Gov't, Non-P.H.S. Jun 2010;95(6):2977-82. Epub 2010/04/16. 
5. Di Iorgi N, Rosol M, Mittelman SD, Gilsanz V. Reciprocal relation between marrow adiposity 
and the amount of bone in the axial and appendicular skeleton of young adults. J Clin Endocrinol 
Metab. Jun 2008;93(6):2281-6. 
6. Wren TA, Chung SA, Dorey FJ, Bluml S, Adams GB, Gilsanz V. Bone marrow fat is inversely 
related to cortical bone in young and old subjects. The Journal of clinical endocrinology and 
metabolism. Mar 2011;96(3):782-6. Epub 2010/12/24. 
7. Shen W, Velasquez G, Chen J, Jin Y, Heymsfield SB, Gallagher D, et al. Comparison of the 
relationship between bone marrow adipose tissue and volumetric bone mineral density in children 
and adults. Journal of clinical densitometry : the official journal of the International Society for 
Clinical Densitometry. Comparative Study 
Research Support, N.I.H., Extramural Jan-Mar 2014;17(1):163-9. Epub 2013/03/26. 
8. Cohen A, Dempster DW, Stein EM, Nickolas TL, Zhou H, McMahon DJ, et al. Increased marrow 
adiposity in premenopausal women with idiopathic osteoporosis. The Journal of clinical 
endocrinology and metabolism. Research Support, N.I.H., Extramural Aug 2012;97(8):2782-91. 
Epub 2012/06/16. 
9. Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M. Adipocyte tissue 
volume in bone marrow is increased with aging and in patients with osteoporosis. 
Biogerontology. Research Support, Non-U.S. Gov't 2001;2(3):165-71. Epub 2001/11/16. 
10. David V, Martin A, Lafage-Proust MH, Malaval L, Peyroche S, Jones DB, et al. Mechanical 
loading down-regulates peroxisome proliferator-activated receptor gamma in bone marrow 
stromal cells and favors osteoblastogenesis at the expense of adipogenesis. Endocrinology. 
Research Support, Non-U.S. Gov't May 2007;148(5):2553-62. Epub 2007/02/24. 
11. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their 
phenotype, differentiation capacity, immunological features, and potential for homing. Stem cells. 
Research Support, Non-U.S. Gov't 
Review Nov 2007;25(11):2739-49. Epub 2007/07/28. 
12. Syed FA, Oursler MJ, Hefferanm TE, Peterson JM, Riggs BL, Khosla S. Effects of estrogen 
therapy on bone marrow adipocytes in postmenopausal osteoporotic women. Osteoporosis 
international : a journal established as result of cooperation between the European Foundation for 
Osteoporosis and the National Osteoporosis Foundation of the USA. Randomized Controlled 
Trial Sep 2008;19(9):1323-30. Epub 2008/02/16. 
This article is protected by copyright. All rights reserved.
25 
 
13. Lecka-Czernik B. Marrow fat metabolism is linked to the systemic energy metabolism. Bone. 
Research Support, N.I.H., Extramural 
Research Support, Non-U.S. Gov't 
Review Feb 2012;50(2):534-9. Epub 2011/07/16. 
14. Fazeli PK, Horowitz MC, MacDougald OA, Scheller EL, Rodeheffer MS, Rosen CJ, et al. 
Marrow fat and bone--new perspectives. J Clin Endocrinol Metab. Mar 2013;98(3):935-45. 
15. Devlin MJ, Rosen CJ. The bone-fat interface: basic and clinical implications of marrow adiposity. 
Lancet Diabetes Endocrinol. Feb 2015;3(2):141-7. 
16. During A, Penel G, Hardouin P. Understanding the local actions of lipids in bone physiology. 
Prog Lipid Res. Jul 2015;59:126-46. 
17. Scheller EL, Cawthorn WP, Burr AA, Horowitz MC, MacDougald OA. Marrow Adipose Tissue: 
Trimming the Fat. Trends Endocrinol Metab. Jun 2016;27(6):392-403. 
18. Whitney DG, Peterson MD, Devlin MJ, Caird MS, Hurvitz EA, Modlesky CM. Bone Marrow Fat 
Physiology in Relation to Skeletal Metabolism and Cardiometabolic Disease Risk in Children 
With Cerebral Palsy. Am J Phys Med Rehabil. Dec 2018;97(12):911-9. Epub 2018/06/13. 
19. Alsahli A, Kiefhaber K, Gold T, Muluke M, Jiang H, Cremers S, et al. Palmitic Acid Reduces 
Circulating Bone Formation Markers in Obese Animals and Impairs Osteoblast Activity via C16-
Ceramide Accumulation. Calcif Tissue Int. May 2016;98(5):511-9. 
20. Gillet C, Spruyt D, Rigutto S, Dalla Valle A, Berlier J, Louis C, et al. Oleate Abrogates 
Palmitate-Induced Lipotoxicity and Proinflammatory Response in Human Bone Marrow-Derived 
Mesenchymal Stem Cells and Osteoblastic Cells. Endocrinology. Nov 2015;156(11):4081-93. 
21. Gunaratnam K, Vidal C, Gimble JM, Duque G. Mechanisms of palmitate-induced lipotoxicity in 
human osteoblasts. Endocrinology. Jan 2014;155(1):108-16. 
22. Elbaz A, Wu X, Rivas D, Gimble JM, Duque G. Inhibition of fatty acid biosynthesis prevents 
adipocyte lipotoxicity on human osteoblasts in vitro. J Cell Mol Med. Apr 2010;14(4):982-91. 
23. Platt ID, El-Sohemy A. Regulation of osteoblast and adipocyte differentiation from human 
mesenchymal stem cells by conjugated linoleic acid. J Nutr Biochem. Dec 2009;20(12):956-64. 
24. Rahman MM, Halade GV, Williams PJ, Fernandes G. t10c12-CLA maintains higher bone 
mineral density during aging by modulating osteoclastogenesis and bone marrow adiposity. J Cell 
Physiol. Sep 2011;226(9):2406-14. 
25. van Heerden B, Kasonga A, Kruger MC, Coetzee M. Palmitoleic Acid Inhibits RANKL-Induced 
Osteoclastogenesis and Bone Resorption by Suppressing NF-kappaB and MAPK Signalling 
Pathways. Nutrients. Apr 28 2017;9(5). 
26. Yeung DK, Griffith JF, Antonio GE, Lee FK, Woo J, Leung PC. Osteoporosis is associated with 
increased marrow fat content and decreased marrow fat unsaturation: a proton MR spectroscopy 
study. J Magn Reson Imaging. Aug 2005;22(2):279-85. 
27. Patsch JM, Li X, Baum T, Yap SP, Karampinos DC, Schwartz AV, et al. Bone marrow fat 
composition as a novel imaging biomarker in postmenopausal women with prevalent fragility 
fractures. Journal of bone and mineral research : the official journal of the American Society for 
Bone and Mineral Research. Research Support, N.I.H., Extramural Aug 2013;28(8):1721-8. Epub 
2013/04/06. 
28. Di Pietro G, Capuani S, Manenti G, Vinicola V, Fusco A, Baldi J, et al. Bone Marrow Lipid 
Profiles from Peripheral Skeleton as Potential Biomarkers for Osteoporosis: A 1H-MR 
Spectroscopy Study. Acad Radiol. Mar 2016;23(3):273-83. 
This article is protected by copyright. All rights reserved.
26 
 
29. Shiran SI, Shabtai L, Ben-Sira L, Ovadia D, Wientroub S. T1-weighted MR imaging of bone 
marrow pattern in children with adolescent idiopathic scoliosis: a preliminary study. J Child 
Orthop. Apr 1 2018;12(2):181-6. Epub 2018/05/01. 
30. Whitney DG, Singh H, Miller F, Barbe MF, Slade JM, Pohlig RT, et al. Cortical bone deficit and 
fat infiltration of bone marrow and skeletal muscle in ambulatory children with mild spastic 
cerebral palsy. Bone. Jan 2017;94:90-7. Epub 2016/11/03. 
31. Modlesky CM, Whitney DG, Singh H, Barbe MF, Kirby JT, Miller F. Underdevelopment of 
trabecular bone microarchitecture in the distal femur of nonambulatory children with cerebral 
palsy becomes more pronounced with distance from the growth plate. Osteoporos Int. Research 
Support, N.I.H., Extramural 
Research Support, Non-U.S. Gov't Feb 2015;26(2):505-12. Epub 2014/09/10. 
32. Ishida K, Aota Y, Mitsugi N, Kono M, Higashi T, Kawai T, et al. Relationship between bone 
density and bone metabolism in adolescent idiopathic scoliosis. Scoliosis. 2015;10:19. 
33. Lam SM, Shui G. Lipidomics as a principal tool for advancing biomedical research. J Genet 
Genomics. Aug 20 2013;40(8):375-90. Epub 2013/08/24. 
34. Wood E, Rosenbaum P. The gross motor function classification system for cerebral palsy: a study 
of reliability and stability over time. Developmental medicine and child neurology. Research 
Support, Non-U.S. Gov't May 2000;42(5):292-6. Epub 2000/06/16. 
35. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem 
Physiol. Aug 1959;37(8):911-7. Epub 1959/08/01. 
36. Morrison WR, Smith LM. Preparation of Fatty Acid Methyl Esters + Dimethylacetals from 
Lipids with Boron Fluoride-Methanol. J Lipid Res. 1964;5(4):600-&. 
37. Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for 
Reliability Research. J Chiropr Med. Jun 2016;15(2):155-63. Epub 2016/06/23. 
38. Bueno-Gracia E, Malo-Urries M, Ruiz-de-Escudero-Zapico A, Rodriguez-Marco S, Jimenez-Del-
Barrio S, Shacklock M, et al. Reliability of measurement of the carpal tunnel and median nerve in 
asymptomatic subjects with ultrasound. Musculoskelet Sci Pract. Dec 2017;32:17-22. Epub 
2017/08/12. 
39. Beninato M, Portney LG. Applying concepts of responsiveness to patient management in 
neurologic physical therapy. J Neurol Phys Ther. Jun 2011;35(2):75-81. Epub 2011/09/22. 
40. Fritz SL, Blanton S, Uswatte G, Taub E, Wolf SL. Minimal detectable change scores for the Wolf 
Motor Function Test. Neurorehabil Neural Repair. Sep 2009;23(7):662-7. Epub 2009/06/06. 
41. Haley SM, Fragala-Pinkham MA. Interpreting change scores of tests and measures used in 
physical therapy. Phys Ther. May 2006;86(5):735-43. Epub 2006/05/03. 
42. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of 
clinical measurement. Lancet. Feb 8 1986;1(8476):307-10. Epub 1986/02/08. 
43. Cook RD. Influential Observations in Linear Regression. Journal of the American Statistical 
Association. 1979/03/01 1979;74(365):169-74. 
44. Cook DR. Residuals and Influence in Regression. New York, NY: Chapman & Hall; 1982. 
45. Naveiras O, Nardi V, Wenzel PL, Hauschka PV, Fahey F, Daley GQ. Bone-marrow adipocytes as 
negative regulators of the haematopoietic microenvironment. Nature. Research Support, N.I.H., 
Extramural 
Research Support, Non-U.S. Gov't Jul 9 2009;460(7252):259-63. Epub 2009/06/12. 
This article is protected by copyright. All rights reserved.
27 
 
46. Menagh PJ, Turner RT, Jump DB, Wong CP, Lowry MB, Yakar S, et al. Growth hormone 
regulates the balance between bone formation and bone marrow adiposity. J Bone Miner Res. Apr 
2010;25(4):757-68. Epub 2009/10/14. 
47. Ecklund K, Vajapeyam S, Mulkern RV, Feldman HA, O'Donnell JM, DiVasta AD, et al. Bone 
marrow fat content in 70 adolescent girls with anorexia nervosa: Magnetic resonance imaging and 
magnetic resonance spectroscopy assessment. Pediatr Radiol. Jul 2017;47(8):952-62. Epub 
2017/04/23. 
48. Ruschke S, Pokorney A, Baum T, Eggers H, Miller JH, Hu HH, et al. Measurement of vertebral 
bone marrow proton density fat fraction in children using quantitative water-fat MRI. MAGMA. 
Oct 2017;30(5):449-60. Epub 2017/04/07. 
49. Bitman J, Wood DL, Mehta NR, Hamosh P, Hamosh M. Lipolysis of triglycerides of human milk 
during storage at low temperatures: a note of caution. J Pediatr Gastroenterol Nutr. 
1983;2(3):521-4. Epub 1983/01/01. 
50. Ishikawa M, Maekawa K, Saito K, Senoo Y, Urata M, Murayama M, et al. Plasma and serum 
lipidomics of healthy white adults shows characteristic profiles by subjects' gender and age. PLoS 
One. 2014;9(3):e91806. Epub 2014/03/19. 
51. Breier M, Wahl S, Prehn C, Fugmann M, Ferrari U, Weise M, et al. Targeted metabolomics 
identifies reliable and stable metabolites in human serum and plasma samples. PLoS One. 
2014;9(2):e89728. Epub 2014/03/04. 
52. Yang W, Chen Y, Xi C, Zhang R, Song Y, Zhan Q, et al. Liquid chromatography-tandem mass 
spectrometry-based plasma metabonomics delineate the effect of metabolites' stability on 
reliability of potential biomarkers. Anal Chem. Mar 5 2013;85(5):2606-10. Epub 2013/02/08. 
53. Taylor LA, Arends J, Hodina AK, Unger C, Massing U. Plasma lyso-phosphatidylcholine 
concentration is decreased in cancer patients with weight loss and activated inflammatory status. 
Lipids Health Dis. Jul 10 2007;6:17. Epub 2007/07/12. 
54. Kudo I, Murakami M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat. Aug 
2002;68-69:3-58. Epub 2002/11/16. 
55. Lessig J, Fuchs B. Plasmalogens in biological systems: their role in oxidative processes in 
biological membranes, their contribution to pathological processes and aging and plasmalogen 
analysis. Curr Med Chem. 2009;16(16):2021-41. Epub 2009/06/13. 
56. Baum T, Yap SP, Karampinos DC, Nardo L, Kuo D, Burghardt AJ, et al. Does vertebral bone 
marrow fat content correlate with abdominal adipose tissue, lumbar spine bone mineral density, 
and blood biomarkers in women with type 2 diabetes mellitus? Journal of magnetic resonance 
imaging : JMRI. Research Support, N.I.H., Extramural Jan 2012;35(1):117-24. Epub 2011/12/23. 
 
This article is protected by copyright. All rights reserved.
28 
 
Table 1. Descriptive characteristics of participants (n=16). 
Cerebral palsy, n (%) 3 (18.8) 
GMFCS, n  
  I-III 0 
  IV 1 
  V 2 
Adolescent idiopathic scoliosis, n 
(%) 13 (81.2) 
Age, mean (SD) 15.1 (1.9) 
Sex, n (%)  
  Female 9 (56.2) 
  Male 7 (43.8) 
Race, n (%)  
  White 13 (81.2) 
  Black 2 (12.5) 
  Refused 1 (6.3) 
Bone marrow samples  
  Thoracic (T) 8 
    T11 4 
    T12 4 
  Lumbar (L) 8 
    L1 3 
    L2 2 
    L3 0 
    L4 3 
























Table 2. Relative and absolute test-retest reliability estimates of lipid composition measures 
from 16 vertebral bone marrow sample pairs. 
 1
st sample 
Mean ± SD 
2nd sample 
Mean ± SD ICC (95% CI) SEM MDC 
Index measures (%) (%) ICC (95% CI) (%) (%) 
  Saturated index 31.07 ± 3.57 31.43 ± 3.53 0.81 (0.55, 0.93) 1.55 4.29 
  Monounsaturated 
index 33.94 ± 5.95 34.56 ± 6.09 0.66 (0.25, 0.87) 3.51 9.73 
  Polyunsaturated index 34.99 ± 5.73 34.01 ± 5.54 0.60 (0.17, 0.84) 3.56 9.88 
Saturated fatty acids      
  15:0 0.10 ± 0.09 0.10 ± 0.09 0.93 (0.82, 0.98) 0.02 0.07 
  18:0 9.77 ± 1.78 10.08 ± 1.79 0.76 (0.44, 0.91) 0.87 2.42 
  24:0 0.55 ± 0.25 0.53 ± 0.27 0.76 (0.43, 0.91) 0.13 0.35 
  16:0 19.39 ± 2.26 19.44 ± 2.54 0.75 (0.42, 0.91) 1.20 3.33 
  20:0 0.17 ± 0.07 0.19 ± 0.06 0.67 (0.29, 0.87) 0.04 0.10 
  14:0 0.59 ± 0.42 0.58 ± 0.37 0.64 (0.21, 0.86) 0.24 0.66 
  22:0 0.30 ± 0.10 0.30 ± 0.10 0.58 (0.12, 0.83) 0.06 0.18 
  12:0 0.01 ± 0.01 0.01 ± 0.01 0.46 (-0.04, 0.77) 0.01 0.02 
  19:0 0.14 ± 0.04 0.14 ± 0.03 0.42 (-0.11, 0.75) 0.03 0.07 
  21:0 0.05 ± 0.04 0.06 ± 0.05 0.10 (-0.42, 0.56) 0.04 0.12 
  13:0 <0.01 ± <0.01 <0.01 ± <0.01 NA NA NA 
Monounsaturated fatty acids     
  24:1 0.63 ± 0.40 0.61 ± 0.33 0.88 (0.69, 0.96) 0.13 0.35 
  14:1n-5 0.11 ± 0.14 0.1 ± 0.09 0.87 (0.67, 0.95) 0.04 0.11 
  16:1n-7t 0.27 ± 0.06 0.26 ± 0.06 0.66 (0.26, 0.87) 0.03 0.10 
  18:1n-9 24.17 ± 9.64 25.83 ± 7.93 0.57 (0.13, 0.83) 5.76 15.97 
  16:1n-7c 1.65 ± 0.58 1.61 ± 0.49 0.56 (0.09, 0.82) 0.35 0.98 
  18:1n-7 6.59 ± 5.71 5.54 ± 3.36 0.53 (0.07, 0.81) 3.11 8.62 
  22:1 0.07 ± 0.04 0.08 ± 0.03 0.35 (-0.12, 0.71) 0.03 0.08 
  20:1 0.46 ± 0.12 0.53 ± 0.17 0.25 (-0.21, 0.64) 0.13 0.35 
Polyunsaturated fatty acids     
  18:3n-3 1.54 ± 2.26 1.39 ± 1.81 0.97 (0.92, 0.99) 0.35 0.98 
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  22:5n-3 0.71 ± 0.39 0.72 ± 0.53 0.85 (0.63, 0.95) 0.18 0.49 
  22:6n-3 0.75 ± 0.41 0.82 ± 0.62 0.81 (0.54, 0.93) 0.22 0.62 
  22:4n-6 0.62 ± 0.27 0.61 ± 0.31 0.80 (0.51, 0.93) 0.13 0.36 
  20:4n-6 4.46 ± 1.67 4.32 ± 1.66 0.68 (0.29, 0.88) 0.94 2.61 
  20:3n-6 0.87 ± 0.33 0.84 ± 0.30 0.67 (0.28, 0.87) 0.18 0.50 
  18:2n-6 25.49 ± 3.66 24.8 ± 2.69 0.58 (0.14, 0.83) 2.06 5.70 
  18:3n-6 0.14 ± 0.08 0.13 ± 0.06 0.53 (0.07, 0.81) 0.05 0.13 
  20:5n-3 0.20 ± 0.33 0.15 ± 0.23 0.42 (-0.08, 0.75) 0.21 0.59 
  20:2 0.19 ± 0.12 0.21 ± 0.14 0.33 (-0.19, 0.70) 0.11 0.29 
  22:2n-6 0.03 ± 0.02 0.03 ± 0.02 0.04 (-0.49, 0.52) 0.02 0.05 
SD, standard deviation; ICC, intraclass correlation coefficient; CI, confidence interval; SEM, 














































Table 3. Relative and absolute test-retest reliability estimates of lipid composition measures 




Mean ± SD 
2nd sample 
Mean ± SD ICC (95% CI) SEM MDC 
Saturated fatty acids (%) (%) ICC (95% CI) (%) (%) 
  20:0 (n=15) 0.18 ± 0.06 0.19 ± 0.06 0.92 (0.77, 0.97) 0.02 0.05 
  19:0 (n=15) 0.14 ± 0.04 0.15 ± 0.03 0.64 (0.21, 0.86) 0.02 0.06 
  21:0 (n=15) 0.05 ± 0.04 0.05 ± 0.02 0.57 (0.09, 0.83) 0.02 0.05 
  12:0 (n=14) <0.01 ± <0.01 <0.01 ± 0.01 0.10 (-0.43, 0.58) <0.01 0.01 
Monounsaturated fatty acids     
  18:1n-9 (n=15) 25.48 ± 8.38 25.27 ± 7.88 0.91 (0.75, 0.97) 2.44 6.76 
  14:1n-5 (n=15) 0.08 ± 0.08 0.08 ± 0.07 0.85 (0.60, 0.95) 0.03 0.08 
  16:1n-7t (n=15) 0.26 ± 0.04 0.25 ± 0.05 0.35 (-0.21, 0.73) 0.04 0.10 
  18:1n-7 (n=14) 4.52 ± 0.71 4.72 ± 0.48 0.17 (-0.38, 0.63) 0.54 1.50 
Polyunsaturated fatty acids     
  18:3n-3 (n=15) 1.00 ± 0.68 0.97 ± 0.69 0.97 (0.91, 0.99) 0.12 0.33 
  20:5n-3 (n=14) 0.09 ± 0.11 0.11 ± 0.17 0.88 (0.66, 0.96) 0.05 0.13 
  22:5n-3 (n=15) 0.64 ± 0.28 0.62 ± 0.34 0.74 (0.38, 0.90) 0.16 0.44 
  22:4n-6 (n=15) 0.58 ± 0.23 0.55 ± 0.24 0.71 (0.33, 0.89) 0.13 0.35 
  22:2n-6 (n=15) 0.03 ± 0.01 0.03 ± 0.02 0.35 (-0.19, 0.73) 0.01 0.03 
  18:3n-6 (n=15) 0.13 ± 0.07 0.12 ± 0.04 0.34 (-0.19, 0.72)  0.04 0.12 
SD, standard deviation; ICC, intraclass correlation coefficient; CI, confidence interval; SEM, 
standard error of measurement; MDC, minimal detectable change.  
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